The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells.
Hazhar Karim, Jamileh Hashemi, Catharina Larsson, Ali Moshfegh, Alan K Fotoohi, Freidoun Albertioni
文献索引:Biochem. Biophys. Res. Commun. 411(1) , 156-61, (2011)
全文:HTML全文
摘要
Exposure of MOLT4 human T-cell leukemia cells to 6-Mercaptopurine (6-MP) and 6-Thioguanine (6-TG) resulted in acquired resistance associated with attenuated expression of the genes encoding concentrative nucleoside transporter 3 (CNT3) and equilibrative nucleoside transporter 2 (ENT2). To identify other alterations at the RNA and DNA levels associated with 6-MP- and 6-TG resistance, we compared here the patterns of gene expression and DNA copy number profiles of resistant sublines to those of the parental wild-type cells. The mRNA levels for two nucleoside transporters were down-regulated in both of the thiopurine-resistant sublines. Moreover, both of these cell lines expressed genes encoding the enzymes of purine nucleotide composition and synthesis, including adenylate kinase 3-like 1 and guanosine monophosphate synthetase at significantly lower levels than wild-type cells. In addition, expression of the mRNA for a specialized DNA polymerase, human terminal transferase encoded by the terminal deoxynucleotidyl transferase (DNTT) gene, was 122- and 93-fold higher in 6-TG- and 6-MP-resistant cells, respectively. The varying responses to 6-MP- and 6-TG observed here may help identify novel cellular targets and modalities of resistance to thiopurines, as well as indicating new potential approaches to individualization therapy with these drugs.Copyright © 2011 Elsevier Inc. All rights reserved.
相关化合物
相关文献:
2012-11-01
[Am. J. Surg. Pathol. 36(11) , 1619-28, (2012)]
2012-07-01
[Bioorg. Med. Chem. Lett. 22(13) , 4428-30, (2012)]
2013-01-01
[J. Craniomaxillofac. Surg. 41(1) , 7-9, (2013)]
2013-05-24
[J. Nat. Prod. 76(5) , 829-38, (2013)]
2012-10-01
[J. Cell Physiol. 227(10) , 3518-27, (2012)]